Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study

Background: Sodium selenite at high dose exerts antitumor effects and increases efficacy of cytostatic drugs in multiple preclinical malignancy models. We assessed the safety and efficacy of intravenous administered sodium selenite in cancer patients’ refractory to cytostatic drugs in a phase I tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Brodin, Ola, Eksborg, Staffan, Wallenberg, Marita, Asker-Hagelberg, Charlotte, Larsen, Erik H., Mohlkert, Dag, Lenneby-Helleday, Clara, Jacobsson, Hans, Linder, Stig, Misra, Sougat, Björnstedt, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488827/
https://www.ncbi.nlm.nih.gov/pubmed/26102212
http://dx.doi.org/10.3390/nu7064978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488827/
https://www.ncbi.nlm.nih.gov/pubmed/26102212
http://dx.doi.org/10.3390/nu7064978

Ejemplares similares